Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia

Abstract

The greater effectiveness of clozapine as compared to conventional medications in refractory schizophrenia is not specific to either negative clinical symptoms or clinical subtypes defined by prominent negative symptoms or evidence of the deficit syndrome.